Baisong Lu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Baisong Lu

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Theranostics|September 29, 2023

Detection of lineage-reprogramming efficiency of tumor cells in a 3D-printed liver-on-a-chip modelZuyan Lu, Xiangwan Miao, Qianqian Song, et al.

Human Gene Therapy|March 30, 2022

The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular DystrophyNalinda B Wasala, Emily D Million, Thais B Watkins, et al.

Molecular Therapy. Advances|July 6, 2026

Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platformRitu M Ramamurthy, Wen Ting Zheng, Sarah E Wachtman, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Theranostics|September 29, 2023

Detection of lineage-reprogramming efficiency of tumor cells in a 3D-printed liver-on-a-chip modelZuyan Lu, Xiangwan Miao, Qianqian Song, et al.

Human Gene Therapy|March 30, 2022

The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular DystrophyNalinda B Wasala, Emily D Million, Thais B Watkins, et al.

Molecular Therapy. Advances|July 6, 2026

Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platformRitu M Ramamurthy, Wen Ting Zheng, Sarah E Wachtman, et al.

Pageof 6